The University of Chicago Header Logo

Connection

Randy Sweis to Carcinoma, Transitional Cell

Back to Details
This is a "connection" page, showing publications Randy Sweis has written about Carcinoma, Transitional Cell.
Randy Sweis
Connection Strength
0.847
Carcinoma, Transitional Cell
  1. Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers. Urol Oncol. 2016 12; 34(12):556-565.
    View in: PubMed
    Score: 0.493
  2. A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma. Eur Urol Oncol. 2024 Aug; 7(4):933-943.
    View in: PubMed
    Score: 0.202
  3. Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer. JAMA Oncol. 2019 12 01; 5(12):1790-1798.
    View in: PubMed
    Score: 0.152
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.